 |
Referenser för PMS
Författare, artikel och publikation |
År
|
Hämta abstract / fulltext
|
1. Andersch B, Wendestam C, Hahn L, Öhman R.
Premenstrual Compalints. I. Prevalence of Premenstrual Symptoms in a Swedish Urban Population.
J Psychosom Obst Gyn 5: 39-49; 1986. |
1986 |
Hämta här |
|
2. Andréen L, Sundström-Poromaa I, Bixo M, Nyberg S, Bäckström T. Allopregnanolone concentration and mood - a bimodal association in postmenopausal women treated with oral progesterone.
Psychopharmacology 187:209-221; 2006. |
2006 |
Hämta här
|
|
3. Bäckström T.
Premenstrual syndrome, In: Current Therapy in Endocrinology and Metabolism,
Bardin CW (ed.)
BC Decker Inc., Philadelphia, 1991 |
1991 |
|
|
4. Bäckström T, Andréen L, Björn I, Johansson IM, Löfgren M. The role of progesterone and GABA in PMS/PMDD.
Chapter 13 in a Textbook on PMS. |
2007 |
Hämta här |
|
5. Bäckström T, Andréen L, Bixo M, Björn I, Fernández G, Johansson IM, Lundgren P, Löfgren M, Nyberg S, Ragagnin G, Poromaa-Sundström I, Strömberg J, van Broekhoven F, van Wingen G, Wang, MD. Neuroactive Steroids in Brain and Relevance to Mood.
Chapter 20 in a Textbook on Psychoneurology. |
2008 |
Hämta här |
6. Halbreich U, Bäckström T, Eriksson E, O'Brien S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E, Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen HU, Yonkers K. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies.
Gynecological Endocrinology 23: 123-130; 2007. |
2007 |
Hämta här |
7. Matsumoto T, Ushiroyama T, Morimura M, Moritani T, Hayashi T, Suzuki T, Tatsumi N. Autonomic nervous system activity in the late luteal phase of eumenorrheic women with premenstrual symptomatology.
J Psychosomatic Ob/Gyn 27: 131-139; 2006. |
2006 |
Hämta här |
8. Matsumoto T, Ushiroyama T, Tatsumi N. Lower peripheral circulation in eumenorrheic young women with premenstrual symptoms.
BioPsychoSocial Medicine 1:8; 2007. |
2007 |
Hämta här |
9. Matsumoto T, Ushiroyama T, Kimura T, Hayashi T, Moritani T. Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder.
Manuscript 2007. |
2007 |
Hämta här |
10. Nyberg S, Bäckström T, Zingmark E, Purdy RH, Sundström-Poromaa I. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
Gynecological Endocrinology 23: 257-266; 2007. |
2007 |
Hämta här |
11. van Wingen GA, van Broekhoven F, Verkes RJ, Petersson KM, Bäckström T, Buitelaar JK, Fernández G. Progesterone selectively increases amygdala reactivity in women.
Molecular Pcychiatry 1-9; 2007. |
2007 |
Hämta här |
|
12. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Obstet Gynecol 2005; 106: 492 - 501. |
2005 |
|
|
13. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dyephoric disorder with a new drospirenone-containing oral contraceptive formulation.
Contraception 2005; 72: 414 - 21. |
2005 |
|
|
14. Segebladh B, Borgström A, Odlind V, Bixo M, Sundström-Poroma I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives.
Contraception 2009; 79: 50 - 55. |
2009 |
Hämta här |
|
15. Ballagh SA, Heyl A. Communicating with women about menstrual cycle symptoms.
J Reprod Med. 2008 Nov; 53(11): 837 - 46. |
2009 |
Hämta här |
|
16. Potter J, Bouver J, Trussell J, Moreau C. Premenstrual syndrome prevalence and fluctuation over time: results from a french population-based survey.
J Womens Health (Larchmt) 2009 Jan-Feb; 18(1): 31 - 9. |
2009 |
Hämta här |
| |
|
|
| |
|
|
| |
|
|
| |
|
| | |
 |
